Kateřina Slavíková

Awards and media
Practice Areas
Industry Sectors

Kateřina Slavíková specialises in pharmaceutical law, medical law, food law, as well as consumer protection, commercial law, personal data protection, and advertising and media regulation in general.

In the area of pharmaceutical law, she has extensive experience in providing day-to-day advice to leading innovative pharmaceutical companies, including managing legal and compliance projects. Kateřina specialises in regulations relating to pharmaceuticals and medical devices, advertising and unfair competition, pricing regulations, clinical trials, and relationships with pharmaceutical distributors and healthcare providers. She also focuses on telemedicine, audits of the handling of personal data and the management of medical records by healthcare providers, and data processing in the context of clinical trials of medicinal products.

In the area of food law, Kateřina specialises primarily in crisis management of food businesses, including food recalls, novel foods, regulation of health and nutrition claims, providing information to consumers, and consumer protection in general.

She also focuses on the regulation of addictive substances, cannabis, cosmetic products, and related areas.

Prior to joining our law firm, Kateřina worked in a multinational company engaged in the sale of food and food for special medical purposes, and in a Czech law firm for several years.

Membership in professional associations

Czech Bar Association

Czech, English
  • Charles University, Faculty of Law, Prague (2014), Mgr. (Master of Laws)
  • Charles University, Media Studies, Prague (2014–2015)
  • comprehensive audit of the handling of personal data and the management of medical records in a group of healthcare providers
  • advisory to a distributor of medical products on processing and transmitting patients’ data via telemedicine
  • advisory to a manufacturer of medical devices regarding its entry to the Czech market
  • comprehensive preparation of terms and conditions for a private health insurance product
  • advisory to healthcare providers on securing payments from the public health insurance system
  • continuous advisory on information about food and food for special medical purposes, including their labelling and advertising
  • regulatory aspects of the pursuit of television broadcasting activities
  • regulation of the sale of alcohol and tobacco, including the option of their distance selling
  • terms and conditions of an e-shop
We are very proud to have been in the legal team lead by Willkie Farr & Gallagher LLP Germany that advised PAI Partners ("PAI") on the acquisition of the majority stake in VAMED Group's rehabilitation business ("VAMED") from Fresenius SE & Co. KGaA. On HAVEL & PARTNERS side, the professionals involved in the transaction were […]
Authors: Kateřina Slavíková, Tomáš Hric, Alžběta Pospíšilová Like many other public health insurance systems worldwide, the Czech public health insurance system also faces challenges concerning sustainable funding and rising healthcare costs, particularly in connection with chronic and rare diseases. This April the Ministry of Health of the Czech Republic therefore introduced a draft amendment to […]
In the 16th year of the Law Firm of the Year Awards in Czechia, HAVEL & PARTNERS, the largest Czech-Slovak law firm, has again won the Best Domestic Law Firm award and become the most popular law firm among clients. HAVEL & PARTNERS has received these two awards for the fourth consecutive year. The firm’s […]
HAVEL & PARTNERS traditionally announces internal promotions at the beginning of the second half of the year. Ondřej Florián, the partner responsible for leading the firm’s corporate and private client services team, becomes an equity partner as of 1 July. Kateřina Slavíková, Jaroslav Baier, Ondrej Čurilla, Petr Opluštil and Miroslav Vozáb have been promoted to […]
Authors: Václav Audes, Kateřina Slavíková, Denisa Fuchsová In late 2021, the European Parliament adopted Regulation (EU) 2021/2282 of the European Parliament and of the Council on health technology assessment (the “Regulation”), which had been under discussion for several years. The European Union hopes that the adoption of the Regulation will establish a joint instrument that […]
Authors: Václav Audes, Kateřina Slavíková On 31 January 2022, the “new” Regulation (EU) No. 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use and repealing Directive 2001/20/EC (the "Regulation") will enter into force. After several delays (the launch was originally planned for […]
HAVEL & PARTNERS, the largest Czech and Slovak law firm, has promoted a total of 14 lawyers with the start of the New Year. Ondřej Majer and Jan Šturm have become equity partners with effect from 1 January 2021. Josef Adam has moved from the position of counsel to partner. In addition, another 11 lawyers […]
Authors: Václav Audes, Jan Diblík, Kateřina Slavíková The coronavirus pandemic has stirred up debates about the need for healthcare in the Czech Republic to be modernised so that it can operate remotely without direct contact with the patient. Telemedicine, as the remote provision of healthcare is called, would reduce unnecessary travel to healthcare appointments or prolonged periods […]


Fill in your e-mail and get regular news from the world of law and business.

Contact Us

Copyright © 2024 HAVEL & PARTNERS s.r.o., advokátní kancelář